Huttner Kenneth 4
4 · LogicBio Therapeutics, Inc. · Filed Feb 13, 2020
Insider Transaction Report
Form 4
Huttner Kenneth
SVP, Head of Clinical Dev.
Transactions
- Award
Stock Option (right to buy)
2020-02-11+50,000→ 50,000 totalExercise: $7.11Exp: 2030-02-11→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% vests on 01/01/2021 and the remainder vests in equal monthly installments over the next 36 months.